XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.80

-0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JAMES WREST who wrote (6780)	7/24/1998 1:28:00 PM
From: aknahow	Read Replies (1) of 17367

James, welcome! I do however think that you are mistaken on the role of the DSMB. Safety is the main concern. Read the XOMA FAQs and look at the use of these safety boards by other companies. Yes BPI ids a host protein, yes it appears safe thus far on over 1,000 patients but any company would be foolhardy to not continue to have an independent board continue to monitor for SAFETY alone not efficiency. While I would not mind a stop for super efficiency, I would not like to see it, if such a stop would result in an inability to demonstrate clear cut statistical evidence that Neuprex produced a significant improvement. IMO trial will continue to the Dec. cut off date.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next